ヘリコバクター・ピロリとヘルミンスの共感染力学:両刃の剣
Barathan Muttiah1, Wathiqah Wahid2, Asrul Abdul Wahab1
1Department of Medical Microbiology and Immunology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia.
International journal of molecular sciences
|August 28, 2025
まとめ
腸内ヘルミントの同時感染は,免疫反応を調節することによって,ヘリコバクター・ピロリ (H. pylori) 誘発の胃疾患から保護することがあります. これらの保護効果を確認するには,さらなるヒト研究が必要である.
科学分野:
- 免疫学
- 流行病学について
- 胃腸内科
背景:
- ヘリコバクター・ピロリ (H. pylori) と腸内ヘルミントは,低所得国や中所得国で多く見られ,しばしば個人を共感染させる.
- ヘルミントは免疫系を調節し 胃の炎症や病気を引き起こします
研究 の 目的:
- H. pylori とヘルミントの共感染の免疫学,疫学,および臨床的側面をレビューする.
- H. pyloriに関連した胃病変に対するヘルミントの潜在的な保護的役割を探求する.
主な方法:
- ヒトとヘルミントの共感染に関する既存の研究と動物モデルのレビュー
- 併感染率と関連する危険因子に関する疫学データの分析
主要な成果:
- ヘルミントはTh2バイアスおよび調節性免疫反応を誘発し,H. pylori誘発のTh1/Th17炎症に対抗する可能性があります.
- 同感染は,免疫を調節し,腸内微生物群を変化させ,ヘルミントが分泌する細胞外小胞を介して,胃組織の損傷と癌のリスクを制限する可能性があります.
- 流行病学的なデータは,特に子供や農村部での共感染率の地域差が大きいことを示しています.
結論:
- ヘルミントの共感染は,H. pyloriに関連した病気に対する免疫保護の可能性を示しています.
- これらの発見を検証するには,さらなるトランスレーション研究とヒト臨床試験が不可欠です.
- 流行地域における公衆衛生戦略は,共感染寄生虫の複雑な相互作用を考慮する必要があります.
関連する概念動画
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
546
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
546
01:28Peptic Ulcer Disease II: Pathophysiology
827
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
827
01:17Gastritis-II: Pathophysiology
542
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
542
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
700
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
700
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
523
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
523
01:30Peptic Ulcer Disease I: Introduction
285
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
285